BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24258161)

  • 21. Carboranylporphyrins for boron neutron capture therapy of cancer.
    Evstigneeva RP; Zaitsev AV; Luzgina VN; Ol' Shevskaya VA; Shtil AA
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):383-92. PubMed ID: 14529446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards new boron carriers for boron neutron capture therapy: metallacarboranes bearing cobalt, iron and chromium and their cholesterol conjugates.
    Białek-Pietras M; Olejniczak AB; Tachikawa S; Nakamura H; Leśnikowski ZJ
    Bioorg Med Chem; 2013 Mar; 21(5):1136-42. PubMed ID: 23357039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetraphenylporphyrin-cobalt(III) bis(1,2-dicarbollide) conjugates: from the solution characteristics to inhibition of HIV protease.
    Kubat P; Lang K; Cígler P; Kozísek M; Matejícek P; Janda P; Zelinger Z; Prochazka K; Kral V
    J Phys Chem B; 2007 May; 111(17):4539-46. PubMed ID: 17425351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
    Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
    Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas.
    Dai C; Cai F; Hwang KC; Zhou Y; Zhang Z; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wei J; Jiao Y; Wei Z; Ma W; Wang R
    Sci China Life Sci; 2013 Feb; 56(2):163-73. PubMed ID: 23334699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cycloimide bacteriochlorin p derivatives: photodynamic properties and cellular and tissue distribution.
    Sharonov GV; Karmakova TA; Kassies R; Pljutinskaya AD; Grin MA; Refregiers M; Yakubovskaya RI; Mironov AF; Maurizot JC; Vigny P; Otto C; Feofanov AV
    Free Radic Biol Med; 2006 Feb; 40(3):407-19. PubMed ID: 16443155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization and biological evaluation of carboranylmethylbenzo[b]acridones as novel agents for boron neutron capture therapy.
    da Silva AF; Seixas RS; Silva AM; Coimbra J; Fernandes AC; Santos JP; Matos A; Rino J; Santos I; Marques F
    Org Biomol Chem; 2014 Jul; 12(28):5201-11. PubMed ID: 24915168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boron-Containing Lipids and Liposomes: New Conjugates of Cholesterol with Polyhedral Boron Hydrides.
    Bregadze VI; Sivaev IB; Dubey RD; Semioshkin A; Shmal'ko AV; Kosenko ID; Lebedeva KV; Mandal S; Sreejyothi P; Sarkar A; Shen Z; Wu A; Hosmane NS
    Chemistry; 2020 Nov; 26(61):13832-13841. PubMed ID: 32521076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography.
    Yanagië H; Ogura K; Takagi K; Maruyama K; Matsumoto T; Sakurai Y; Skvarc J; Illic R; Kuhne G; Hisa T; Yoshizaki I; Kono K; Furuya Y; Sugiyama H; Kobayashi H; Ono K; Nakagawa K; Eriguchi M
    Appl Radiat Isot; 2004 Oct; 61(4):639-46. PubMed ID: 15246411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT).
    Luguya R; Fronczek FR; Smith KM; Vicente MG
    Appl Radiat Isot; 2004 Nov; 61(5):1117-23. PubMed ID: 15308202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption.
    Lee CS; Park W; Park SJ; Na K
    Biomaterials; 2013 Dec; 34(36):9227-36. PubMed ID: 24008035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model.
    Petersen MS; Petersen CC; Agger R; Sutmuller M; Jensen MR; Sørensen PG; Mortensen MW; Hansen T; Bjørnholm T; Gundersen HJ; Huiskamp R; Hokland M
    Anticancer Res; 2008; 28(2A):571-6. PubMed ID: 18506994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
    Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.